Zimmer Biomet Holdings, Inc. (ZBH) posted first-quarter 2025 adjusted earnings per share (EPS) of $1.81, which beat the Zacks Consensus Estimate by 2.3%. The adjusted figure, however, declined 6.7% year over year.The quarter’s adjustments included certain amortization, restructuring and other cost reduction initiatives, inventory and manufacturing-related charges and European Union Medical Device Regulation-related charges, among others.On a reported basis, the company registered earnings of 91 cents per sh ...

Zimmer Biomet (ZBH) reported $1.91 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.1%. EPS of $1.81 for the same period compares to $1.94 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.89 billion, representing a surprise of +0.88%. The company delivered an EPS surprise of +2.84%, with the consensus EPS estimate being $1.76.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stre ...

Wall Street analysts forecast that Zimmer Biomet (ZBH) will report quarterly earnings of $1.77 per share in its upcoming release, pointing to a year-over-year decline of 8.8%. It is anticipated that revenues will amount to $1.89 billion, exhibiting an increase of 0.2% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before ...